Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation

by Jorn Mulder, Tobias van Rossum, Segundo Mariz, Armando Magrelli, Anthonius de Boer, Anthonius de Boer, Anna M. G. Pasmooij, Violeta Stoyanova-Beninska
Published 2021-12-01

A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach

by Jorn Mulder, Odile C. van Stuijvenberg, Paula B. van Hennik, Emile E. Voest, Emile E. Voest, Anna M. G. Pasmooij, Violeta Stoyanova-Beninska, Anthonius de Boer, Anthonius de Boer
Published 2022-06-01

Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.

by Yaser T Bazargani, Anthonius de Boer, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse
Published 2014-01-01

Essential medicines are more available than other medicines around the globe.

by Yaser T Bazargani, Margaret Ewen, Anthonius de Boer, Hubert G M Leufkens, Aukje K Mantel-Teeuwisse
Published 2014-01-01

Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia.

by Miriam J Warnier, Frans H Rutten, Anthonius de Boer, Arno W Hoes, Marie L De Bruin
Published 2014-01-01

Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

by Fariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, Geoffrey Liu, Anke H Maitland-van der Zee
Published 2015-01-01

Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Control...

by Fariba Ahmadizar, N Charlotte Onland-Moret, Anthonius de Boer, Geoffrey Liu, Anke H Maitland-van der Zee
Published 2015-01-01

Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders

by Jorn Mulder, Robin Verjans, Ciska Verbaanderd, Ciska Verbaanderd, Elias Pean, Just Weemers, Hubert G. M. Leufkens, Francesco Pignatti, Anthonius de Boer, Anthonius de Boer, Emile E. Voest, Emile E. Voest, Violeta V. Stoyanova-Beninska, Anna M. G. Pasmooij
Published 2021-12-01

Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

by Grace Wangge, Olaf H Klungel, Kit C B Roes, Anthonius de Boer, Arno W Hoes, Mirjam J Knol
Published 2010-01-01

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.

by Talip E Eroglu, Marieke T Blom, Patrick C Souverein, Alfi Yasmina, Anthonius de Boer, Hanno L Tan, ESCAPE-NET investigators
Published 2022-01-01

Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study

by Talip E. Eroglu, Marieke T. Blom, Patrick C. Souverein, Alfi Yasmina, Anthonius de Boer, Hanno L. Tan, for the ESCAPE-NET investigators
Published 2022-01-01

Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes

by Özlem Bozkurt, Anthonius de Boer, Diederik E Grobbee, Abraham A Kroon, Paul Schiffers, Peter de Leeuw, Olaf H Klungel
Published 2009-06-01

Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov

by Anthonius de Boer, Helga Gardarsdottir, Amos J de Jong, Renske J Grupstra, Yared Santa-Ana-Tellez, Mira G P Zuidgeest
Published 2022-08-01

Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors

by Anthonius de Boer, Damiaan A J P Denys, Sem E Cohen, Jasper Brian Zantvoord, Bram W C Storosum, Taina Kristiina Mattila
Published 2024-06-01

Number of patients studied prior to approval of new medicines: a database analysis.

by Ruben G Duijnhoven, Sabine M J M Straus, June M Raine, Anthonius de Boer, Arno W Hoes, Marie L De Bruin
Published 2013-01-01

Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study.

by Rogier Wvan der Zanden, Frank de Vries, Arief Lalmohamed, Johanna H M Driessen, Anthonius de Boer, Gernot Rohde, Cees Neef, Casper den Heijer
Published 2015-01-01

Disease history and medication use as risk factors for the clinical manifestation of type 1 diabetes in children and young adults: an explorative case control study.

by Soulmaz Fazeli Farsani, Patrick C Souverein, Marja M J van der Vorst, Aukje K Mantel-Teeuwisse, Catherijne A J Knibbe, Anthonius de Boer
Published 2014-01-01

Association between perioperative statin treatment and short-term clinical outcomes following transcatheter aortic valve implantation: a retrospective cohort study

by Michiel Voskuil, Anthonius de Boer, Marcel Bouvy, Wilma Knol, Huiberdina L Koek, Adriaan O Kraaijeveld, Lauren Dautzenberg, Marielle Emmelot-Vonk, Geert Lefeber, Carla Huijbers
Published 2023-11-01

Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: a systematic review and meta-analysi...

by Anthonius de Boer, Joost Daams, Damiaan A J P Denys, Sem E Cohen, Jasper Brian Zantvoord, Bram W C Storosum, Taina Kristiina Mattila, Babet Wezenberg
Published 2024-02-01

Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study

by Amr Makady, Rachel R. J. Kalf, Bettina Ryll, Gilliosa Spurrier, Anthonius de Boer, Hans Hillege, Olaf H. Klungel, Wim Goettsch, on behalf of GetReal Workpackage 1
Published 2018-11-01